Wireless EEG headset could enable at-home stroke rehabilitation

The world of at-home stroke rehabilitation is growing near, incredible news for the 795,000 people in the United States who annually suffer a stroke.

Erasca’s ERAS-801 secures FDA orphan drug designation

Erasca’s ERAS-801 will be used to treat malignant glioma, including glioblastoma. Credit: Nemes Laszlo / Shutterstock.com. Erasca has obtained orphan drug designation (ODD) from the

June 23, 2023

Exercise unleashes anti-inflammatory power against autoimmune diseases

The impact of exercise training on reducing inflammation in adolescents and adults with autoimmune diseases.

February 19, 2024

Low Relapse Rates With Twice-Yearly Schizophrenia Treatment

Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported during a poster

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.